Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

PDMR Dealings

21 Apr 2017 13:07

RNS Number : 0175D
Jarvis Securities plc
21 April 2017
 

Jarvis Securities plc

("Jarvis" or the "Company")

 

PDMR Dealings

Substantial Shareholder Notifications

 

The Company has received notice today that, pursuant to a restructuring of its significant shareholder Sion Securities Limited ("Sion"), Sion which on 16 October 2015 was put into a solvent Members Voluntary Liquidation) and the beneficial ownership of the underlying shares in Jarvis these have now been transferred to the shareholders of Sion on 20 April 2017 for nil consideration. The shares will continue to be legally held by JIM Nominees Limited.

 

As consequence of this transaction, and subsequent minor transfers between members of the Grant family, Andrew Grant, a director of the Company, now holds a direct beneficial interest in 3,026,405 Ordinary Shares in the Company, including 87,150 Ordinary shares held in his SIPP, (which represents 27.5% of the current issued shares of the Company) and an indirect interest in 1,126,239 Ordinary Shares in the Company, held in the name of his wife, Jane Grant. In total, Andrew Grant is interested in 4,152,644 Ordinary Shares representing 37.18% of the issued share capital.

 

In addition, two other substantial shareholders have today notified a change in interest in their shareholdings, as a consequence of this transaction:

 

Name of Shareholder

Number of Shares Beneficially Held

Interest in the Company (%)

Florence Elizabeth Grant

1,063,518

9.67

Lionel George Grant

513,630

4.67

 

Commenting on the transaction CEO, Andrew Grant said "We believe this restructuring is a positive step for the Company and provides greater transparency and clarity as to the underlying shareholders of Jarvis, showing the precise holdings of each member of the Grant family. It also puts greater control over the shareholdings into the hands of the individual shareholders and demonstrates that no one single shareholder holds over 50% of the issued shares, which we believe will be positively received by current and future investors. "

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on shares acquired.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Andrew Grant

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Jarvis Securities plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p

 

 

GB00B013J330

 

b)

Nature of the transactions

Transfer of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

nil

2,939,255

 

d)

Aggregated information

- Aggregated volume

- Price

 

2,939,255

nil

e)

Date of the transaction

20 April 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

 

Enquiries:

 

Jarvis Securities plc 01892 510 515

Andrew Grant

Jolyon Head

 

WH Ireland Limited 0113 394 6600

Katy Mitchell

Ed Allsopp

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHIBMTTMBMTBAR
Date   Source Headline
29th May 20262:10 pmRNSResult of GM
12th May 202611:55 amRNSNotice of GM
8th May 202611:57 amRNSConditional Property Sale, RPT & Proposed GM
5th May 20267:00 amRNSUpdate on JIML
30th Mar 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSResult of GM
27th Jan 20267:00 amRNSNon-Executive Director Appointment
15th Jan 20262:52 pmRNSHolding(s) in Company
30th Dec 20257:00 amRNSAudited Results, FCA Update & Notice of GM
30th Dec 20257:00 amRNSAudited Results, FCA Update & Notice of GM
23rd Dec 202511:47 amRNSHolding(s) in Company
23rd Dec 202511:47 amRNSHolding(s) in Company
23rd Dec 202511:25 amRNSHolding(s) in Company
23rd Dec 202511:25 amRNSHolding(s) in Company
23rd Dec 202511:09 amRNSBoard Change
23rd Dec 202511:09 amRNSBoard Change
19th Dec 20254:14 pmRNSHolding(s) in Company
19th Dec 20254:14 pmRNSHolding(s) in Company
19th Dec 20254:07 pmRNSResult of AGM
19th Dec 20254:07 pmRNSResult of AGM
11th Dec 20258:20 amRNSNotice of AGM
30th Sep 202510:20 amRNSAccounts Timetable Update
31st Jul 20254:30 pmRNSDividend Declaration and Company Update
7th Jul 20259:18 amRNSSale of Retail Execution-only Brokerage Business
27th Jun 20257:05 amRNSSecond Interim Results
27th Jun 20257:00 amRNSChange of Accounting Reference Date
15th Apr 20253:00 pmRNSSale of Retail Brokerage & Strategic Direction
20th Feb 20257:00 amRNSDividend Declaration
14th Nov 20247:00 amRNSDividend Declaration
25th Oct 202410:25 amRNSHolding(s) in Company
25th Oct 202410:24 amRNSHolding(s) in Company
25th Oct 202410:22 amRNSHolding(s) in Company
25th Oct 202410:19 amRNSHolding(s) in Company
23rd Oct 202412:41 pmRNSDirector / PMDR Shareholding
30th Aug 20245:08 pmRNSTR - 1
30th Aug 202412:02 pmRNSTR - 1
30th Aug 202412:00 pmRNSTR - 1
30th Aug 202412:00 pmRNSTR - 1
8th Aug 20247:01 amRNSDividend Declaration
8th Aug 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
27th Jun 20247:25 amRNSUpdate
9th May 20247:00 amRNSDIVIDEND DECLARATION
18th Apr 20244:20 pmRNSANNUAL GENERAL MEETING
18th Apr 20244:11 pmRNSProxy Votes
17th Apr 20244:15 pmRNSStrategic Update
26th Mar 20247:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
15th Feb 20247:00 amRNSDividend Declaration
13th Nov 202312:52 pmRNSDividend and Company Update
31st Oct 20232:35 pmRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.